[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Prescription Drug Marketing; Administrative...[ Price : $8.95]
A House Appropriations Subcommittee approves by voice vote FDAs s fiscal year 2022 budget bill that would increase the agencys bud...[ Price : $8.95]
Avid Medical recalls (Class 1) medical convenience kits that include the BD/Carefusion Chloraprep 3mL applicator due to the risk o...[ Price : $8.95]
FDA publishes a draft guidance to encourage the inclusion of some patients with incurable cancers in trials of new cancer therapie...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Covid 19: Master Protocols Evaluating Drugs and Biological ...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Novartis Zolgensma.[ Price : $8.95]
Reps. DeGette and Upton propose language for a Cures 2.0 bill circulating in Congress to create the Advanced Research Projects Age...[ Price : $8.95]
The Oncology Drug Advisory Committee recommends that FDA not take action to approve Incytes retifanlimab for squamous carcinoma of...